World Alzheimer’s Day Highlights the Need for Innovation
Brussels 21 September
In Europe and worldwide, thanks to advances in the understanding of the dynamics of the disease that are being made at the genetic and molecular levels, healthcare biotech companies, both large and small, are working relentlessly on early detection and prevention to address the life-altering symptoms posed by Alzheimer’s disease- the most common cause of dementia globally.